ATSN-201 Gene Therapy in RS1-Associated X-linked Retinoschisis

Clinical trial NCT05878860 · RECRUITING

Trial details

NCT number: NCT05878860
Sponsor: Atsena Therapeutics Inc.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

X-linked Retinoschisis

Start date: 2023-08-22
Primary completion: 2028-04-01
Enrollment: 97

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.